Literature DB >> 1116221

Enhanced renal prostaglandin production in the dog. II. Effects on intrarenal hemodynamics.

L C Chang, J A Splawinski, J A Oates, A S Nies.   

Abstract

The effects of enhanced endogenous production of prostaglandins by the kidney on the distribution of blood flow in the renal cortex were assessed by infusing sodium arachidonate, the precursor of the renal prostaglandins, into one renal artery of the dog. The changes produced with arachidonate (3 times 10--6 g/kg min-1 and 10--5 g/kg min--1) were compared with those produced by infusions of prostaglandin (PG) E2 (10--7 g/kg min--1) and PGF2alpha (3 times 10--7 g/kg min--1) into one renal artery. Distribution of renal blood flow was measured by the radioactive microsphere technique. Sodium arachidonate caused an increase in blood flow to the inner cortical zones with no change in flow to the nephrons in the outermost quarter of the cortex. PGE2 increased flow to all cortical zones, and PGF2alpha produced no change in flow. Since arterial blood pressure did not change, changes in vascular resistance were reciprocal to changes in flow. Thus, vascular resistance fell in the inner cortical regions but not in the outer regions, with arachidonate infusions and in all regions of the cortex with PGE2 infusions; no changes were seen with PGF2alpha infusions. These data indicate that prostaglandin formed endogenously in the kidney affects the vascular resistance of only the inner cortical nephrons; the data thus support the hypothesis that renal prostaglandins are one mediator of renal autoregulation of blood flow.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1116221     DOI: 10.1161/01.res.36.1.204

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  11 in total

1.  Role of endoperoxides in arachidonic acid-induced vasoconstriction in the isolated perfused kidney of the rat.

Authors:  J Quilley; J C McGiff; A Nasjletti
Journal:  Br J Pharmacol       Date:  1989-01       Impact factor: 8.739

2.  Changes in renal medullary pO2 during water diuresis as evaluated by blood oxygenation level-dependent magnetic resonance imaging: effects of aging and cyclooxygenase inhibition.

Authors:  P V Prasad; F H Epstein
Journal:  Kidney Int       Date:  1999-01       Impact factor: 10.612

3.  Renal blood flow autoregulation and renal venous prostaglandins in the pump-perfused canine kidney (in situ).

Authors:  K K Dighe; J C Hall; G W Smith; A Ungar
Journal:  Br J Pharmacol       Date:  1977-04       Impact factor: 8.739

Review 4.  Physiology and pharmacology of prostaglandins.

Authors:  S J Konturek; W Pawlik
Journal:  Dig Dis Sci       Date:  1986-02       Impact factor: 3.199

5.  Renal function in conscious rats after indomethacin. Evidence for a tubular action of endogenous prostaglandins.

Authors:  J Haylor; C J Lote
Journal:  J Physiol       Date:  1980-01       Impact factor: 5.182

6.  Reliability of the measurement of intrarenal haemodynamics in the dog, as determined by the radioactive microsphere technique.

Authors:  K László; J Juszkó; P Bálint
Journal:  Int Urol Nephrol       Date:  1981       Impact factor: 2.370

7.  Inhibition of sodium transport by prostaglandin E2 across the isolated, perfused rabbit collecting tubule.

Authors:  J B Stokes; J P Kokko
Journal:  J Clin Invest       Date:  1977-06       Impact factor: 14.808

8.  Sodium chloride as regulator of renal prostaglandin E2 production in patients with essential hypertension.

Authors:  R A Stahl; A J Jonassen; M Paravicini; P Schollmeyer
Journal:  Klin Wochenschr       Date:  1982-06-01

9.  Renal vasoconstrictor response to hypertonic saline in the dog: effects of prostaglandins, indomethacin and theophylline.

Authors:  J G Gerber; A S Nies
Journal:  J Physiol       Date:  1986-11       Impact factor: 5.182

10.  PGE2 concentrations in renal venous plasma and renal lymph during basal and stimulated conditions in the dog.

Authors:  R M Hohenfellner; J Rehbock; H Brechtelsbauer; H G Klein; K Thurau
Journal:  Pflugers Arch       Date:  1989-04       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.